CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...